29
Nongene’c, Exposurerelated Mitochondrial Disease (“Mitochondrial Toxicity”) Kendall B. Wallace, Ph.D., DABT, ATS Professor & Associate Dean University of Minnesota Medical School Duluth campus

Mitochondrial Disease and Toxins

Embed Size (px)

Citation preview

  • Non-gene'c, Exposure-related Mitochondrial Disease

    (Mitochondrial Toxicity)

    Kendall B. Wallace, Ph.D., DABT, ATS Professor & Associate Dean

    University of Minnesota Medical School Duluth campus

  • Mitochondrial Disease

    Mul'-organ clinical presenta'on Metabolic phenotype Progressive

    E'ology

    Gene'c Somatogenic/acquired (toxicity)

    2

  • Mitochondrial Disease Etiology 1.Genetic

    mutations to nuclear (nDNA) &/or mitochondrial DNA (mtDNA)

    Heritable X-chromosome

    Mito Map

    3

  • Mitochondrial Electron Transport Chain

    nDNA 35 4 10 10 12 mtDNA 7 0 1 3 2

    4

    Gene'c Mitochondria Disease Founda'ons

  • Mitochondrial Disease Etiology

    2. Somatogenic/acquired Mitochondrial Toxicity

    Pharmaceutical

    Environmental

    Occupational

    5

  • Mito Ac'on Broadcasts (drug-induced mitochondrial disease)

    May 1, 2009

    Dr. James Dykens, Pfizer Pharmaceu'cals Drug Toxicity and Pharmaceu'cals

    June 4, 2010 Dr. Katherine Sims from Massachuse[s General Hospital Mitochondrial Toxicity

    6

  • Mul'ple Targets for Drug-induced Mitochondrial Toxicity

    (Wallace, K.B. Curr Med Chem. 2015 May 13)

    7

  • Chemical Targe'ng to Mitochondria

    Drugs & chemicals are not distributed equally throughout the cell Cardiolipin

    Electrical membrane poten'al

    h[p://figshare.com/ar'cles/_Structure_of_Cardiolipin_/658399

    8

  • Krebs Cycle

    e- e-

    e- e-

    H+H+ H+H+

    Cyt C e- e-

    H+H+ O2 H+H+ H2O

    ADP ATP

    Cyt C

    e-

    O2

    Q

    H+`H+

    NADH

    NAD+

    H+ H+ H+ H+H+H+

    Cyt C

    H+`

    e- e- e-

    Modified from: Peter S. Rabinwitch after Mandavilli et al, Mutation Research 509 (2002) 127151

    2OH- OH-

    Mitochondrial Electron Transport Chain

    9

    Transmembrane potentials: ~ 1 pH unit alkaline matrix ~ 180 mV negative matrix

  • Image modified from: h[p://www.westernspring.co.uk/how-small-gene'c-differences-give-racial-diversity/

    Posi'vely charged chemicals are drawn from the cell contents into and accumulate in mitochondria

    10

    Acids & bases

  • K.B.Wallace, Mito AcEon Oct. 2, 2015

    Pharmaceu'cal Uncouplers of Mitochondrial Respira'on:

    Amphetamines, doxorubicin, Flufenamic acid, Diflunisal, Tolfenamic acid, Mefenamic acid, Diclofenac, Indomethacin, Naproxen, Nimuesulide

    11

  • Chemical Inhibitors of Mitochondrial Electron Transport

    Rotenone

    Menadione Benzoquinone

    Cyanide CO H2S

    K.B.Wallace, Mito AcEon Oct. 2, 2015

    Chemical Uncouplers of Mitochondrial RespiraEon Pentachlorophenol Heavy metals: Pb2+, As2+, Cd2+, Hg2+ Paraquat perfluorosulfonamide

    12

  • OXIDATIVE PHOSPHORYLATION!

    Chemical-induced Mitochondrionopathies

    TCA!Cycle!

    NAD+

    NADH

    METABOLISM!

    Glucose

    Pyruvate

    LACTIC ACID

    NAD+

    NADH

    IODOACETATE

    DICHLOROACETATE

    Acetyl CoA

    oxida>on

    NAD+

    NADH

    NAD+

    NADH

    FLUOROACETATE FLUOROACETAMIDE

    VALPROIC ACID SALICYLATES

    FaEy acids

    mtDNA

    GENETIC MECHANISMS!

    replica>on

    NUCLEOSIDE ANALOGUES

    transcrip'on

    ANTIBIOTICS

    ROTENONE MALONYL CoA ANTIMYCIN A

    CYANIDE

    e- NAD+

    NADH

    [H+]

    [H+]

    PHENOLS, AMIDES AMPHIPHILIC CATIONS QUINONES

    H+

    ADP

    ATP

    transla'on

    PROTEIN TRANSLOCALIZATION!

    HSPs

    PROTEASE INHIBITORS

    13

    The Bigger Picture of Mitochondrial Toxicity

    Substrate delivery Molecular organizaEon

  • h[ps://en.wikipedia.org/wiki/Electron_transport_chain 14

  • 15

    Aspirin, Ibuprofen Valproic acid

    Fluoroacetate Fluoroacetamide

    Dichloroacetate

  • OXIDATIVE PHOSPHORYLATION!

    Chemical-induced Mitochondrionopathies

    TCA!Cycle!

    NAD+

    NADH

    METABOLISM!

    Glucose

    Pyruvate

    LACTIC ACID

    NAD+

    NADH

    IODOACETATE

    DICHLOROACETATE

    Acetyl CoA

    oxida>on

    NAD+

    NADH

    NAD+

    NADH

    FLUOROACETATE FLUOROACETAMIDE

    VALPROIC ACID SALICYLATES

    FaEy acids mtDNA

    GENETIC MECHANISMS!

    replica>on

    NUCLEOSIDE ANALOGUES

    transcrip'on

    ANTIBIOTICS

    ROTENONE MALONYL CoA ANTIMYCIN A

    CYANIDE

    e- NAD+

    NADH

    [H+]

    [H+]

    PHENOLS, AMIDES AMPHIPHILIC CATIONS QUINONES

    H+

    ADP

    ATP

    transla'on

    PROTEIN TRANSLOCALIZATION!

    HSPs

    PROTEASE INHIBITORS

    Summary update

    16

  • Molecular Targets for Mitochondrial Toxicity

    From the mitochondrial or nuclear genome to protein incorporated into the mitochondrial structure Gene transla'on Protein synthesis Protein transloca'on and assembly

    17

  • OXIDATIVE PHOSPHORYLATION!

    Chemical-induced Mitochondrionopathies

    TCA!Cycle!

    NAD+

    NADH

    METABOLISM!

    Glucose

    Pyruvate

    LACTIC ACID

    NAD+

    NADH

    IODOACETATE

    DICHLOROACETATE

    Acetyl CoA

    oxida>on

    NAD+

    NADH

    NAD+

    NADH

    FLUOROACETATE FLUOROACETAMIDE

    VALPROIC ACID SALICYLATES

    FaEy acids

    mtDNA

    GENETIC MECHANISMS!

    replica>on

    NUCLEOSIDE ANALOGUES

    transcrip'on

    ANTIBIOTICS

    ROTENONE MALONYL CoA ANTIMYCIN A

    CYANIDE

    e- NAD+

    NADH

    [H+]

    [H+]

    PHENOLS, AMIDES AMPHIPHILIC CATIONS QUINONES

    H+

    ADP

    ATP

    transla'on

    PROTEIN TRANSLOCALIZATION!

    HSPs

    PROTEASE INHIBITORS

    18

  • Depolarize membrane poten'al Protease inhibitors

    nDNA muta'ons Cytosolic ribosomes Precursor processing

    19

  • OXIDATIVE PHOSPHORYLATION!

    Chemical-induced Mitochondrionopathies

    TCA!Cycle!

    NAD+

    NADH

    METABOLISM!

    Glucose

    Pyruvate

    LACTIC ACID

    NAD+

    NADH

    IODOACETATE

    DICHLOROACETATE

    Acetyl CoA

    oxida>on

    NAD+

    NADH

    NAD+

    NADH

    FLUOROACETATE FLUOROACETAMIDE

    VALPROIC ACID SALICYLATES

    FaEy acids

    mtDNA

    GENETIC MECHANISMS!

    replica>on

    NUCLEOSIDE ANALOGUES

    transcrip'on

    ANTIBIOTICS

    ROTENONE MALONYL CoA ANTIMYCIN A

    CYANIDE

    e- NAD+

    NADH

    [H+]

    [H+]

    PHENOLS, AMIDES AMPHIPHILIC CATIONS QUINONES

    H+

    ADP

    ATP

    transla'on

    PROTEIN TRANSLOCALIZATION!

    HSPs

    PROTEASE INHIBITORS

    20

  • mtDNA replica'on and transla'on

    21

  • h[ps://www.flickr.com/photos/5winfographics/9034866105 22

  • 23

    Examples of NRTIs

  • h[p://www.hva'nn.is/frodleiksmolar/hvad-er-rna/

    24

    An'bio'cs Chloramphenicol Tetracycline Linezolid

    Mitochondrial Protein Synthesis Inhibitors

  • OXIDATIVE PHOSPHORYLATION!

    Chemical-induced Mitochondrionopathies

    TCA!Cycle!

    NAD+

    NADH

    METABOLISM!

    Glucose

    Pyruvate

    LACTIC ACID

    NAD+

    NADH

    IODOACETATE

    DICHLOROACETATE

    Acetyl CoA

    oxida>on

    NAD+

    NADH

    NAD+

    NADH

    FLUOROACETATE FLUOROACETAMIDE

    VALPROIC ACID SALICYLATES

    FaEy acids

    mtDNA

    GENETIC MECHANISMS!

    replica>on

    NUCLEOSIDE ANALOGUES

    transcrip'on

    ANTIBIOTICS

    ROTENONE MALONYL CoA ANTIMYCIN A

    CYANIDE

    e- NAD+

    NADH

    [H+]

    [H+]

    PHENOLS, AMIDES AMPHIPHILIC CATIONS QUINONES

    H+

    ADP

    ATP

    transla'on

    PROTEIN TRANSLOCALIZATION!

    HSPs

    PROTEASE INHIBITORS

    25

  • Other uncharacterized Environmental Mitochondrial Toxici'es

    Cigare[e smoke Air pollu'on, par'culates Poly aroma'c hydrocarbons (PAHs) Herbicides 2,4-dichlorophenoxyace'c acid (2,4-D), dinoseb

    mtDNA genotoxicants, mutagens etc.

    26

  • 27

    Reports of demonstrated mitochondrial toxicity represent a hazard that may or may not be a real risk under normal or intended exposure condi'ons. hazard versus risk

  • Extended Readings Dykens, J.A. and Will, Y. (2007) The significance of mitochondrial toxicity tes'ng in drug

    development. Drug Discovery Today, 12, 777-785. Wallace, K.B. Mitochondrial Off-Targets of Drug Therapy. 2008. Trends in Pharmacological

    Sciences. 29, 361-366. Cohen BH. (2010) Pharmacologic effects on mitochondrial func'on. Dev. Disabil Res Rev. 16,

    189-199. Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., and Fromenty, B. (2011). Drug-

    induced toxicity on mitochondria and lipid metabolism: Mechanis'c diversity and deleterious consequences for the liver. J. Hepatology 54, 773-794.

    Meyer JN, Leung MC, Rooney JP, Sendoel A, Hengartner MO, Kisby GE, Bess AS. (2013). Mitochondria as a target of environmental toxicants. Toxicol Sci. 134, 1-17

    Wallace, K.B. (2014). Drug-induced mitochondrial neuropathy in children: A conceptual framework for cri'cal windows of development. J. Child Neurology 29, 1241-1248.

    Wallace, K.B. (2015). Mul'ple targets for drug-induced mitochondrial toxicity. (Current Medicinal Chemistry, 22, in press).

    28

  • Mitochondrial Disease v. Mitochondrial Toxicity

    Genetic v. Environmental

    Thank you

    29